Attached files
file | filename |
---|---|
10-Q/A - 10-Q/A - PLUS THERAPEUTICS, INC. | d676646d10qa.htm |
EX-31.1 - EX-31.1 - PLUS THERAPEUTICS, INC. | d676646dex311.htm |
EX-10.93 - EX-10.93 - PLUS THERAPEUTICS, INC. | d676646dex1093.htm |
Exhibit 31.2
Certification of Principal Financial Officer Pursuant to
Securities Exchange Act Rule 13a-14(a),
as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Mark E. Saad, certify that:
1. | I have reviewed this quarterly report on Form 10-Q/A of Cytori Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: February 12, 2014 |
/s/ Mark E. Saad |
Mark E. Saad |
Chief Financial Officer |